Subjects receiving other overactive bladder treatment failed to notice decline in their memory function These data provide further information about Enablex, an effective overactive bladder treatment ...
East Hanover, December 22, 2004 – Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback